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Abstract
Mouse aldehyde oxidase (mAOX1) forms a homodimer and belongs to the xanthine oxidase family of molybdoenzymes
which are characterized by an essential equatorial sulfur ligand coordinated to the molybdenum atom. In general,
mammalian AOs are characterized by broad substrate specificity and an yet obscure physiological function. To define the
physiological substrates and the enzymatic characteristics of mAOX1, we established a system for the heterologous
expression of the enzyme in Eschericia coli. The recombinant protein showed spectral features and a range of substrate
specificity similar to the native protein purified from mouse liver. The EPR data of recombinant mAOX1 were similar to those
of AO from rabbit liver, but differed from the homologous xanthine oxidoreductase enzymes. Site-directed mutagenesis of
amino acids Val806, Met884 and Glu1265 at the active site resulted in a drastic decrease in the oxidation of aldehydes with
no increase in the oxidation of purine substrates. The double mutant V806E/M884R and the single mutant E1265Q were
catalytically inactive enzymes regardless of the aldehyde or purine substrates tested. Our results show that only Glu1265 is
essential for the catalytic activity by initiating the base-catalyzed mechanism of substrate oxidation. In addition, it is
concluded that the substrate specificity of molybdo-flavoenzymes is more complex and not only defined by the three
characterized amino acids in the active site.
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Introduction
The molybdenum cofactor (Moco) is found in a class of widely
distributed proteins collectively known as molybdoenzymes. Moco
containing enzymes are divided into three separate groups on the
basis of structure, cofactor and spectroscopic characteristics: the
dimethylsulfoxide (DMSO) reductase, the xanthine oxidase, and
the sulfite oxidase family [1]. Members of the xanthine oxidase
family comprise xanthine dehydrogenase (XDH, EC 1.17.1. 4),
xanthine oxidase (XO, EC 1.17.3.2), and aldehyde oxidase (AO,
EC 1.2.3.1). All these proteins are characterized by an equatorial
sulfur ligand at the Moco essential for the enzymatic activity [2],
and belong to the class of complex molybdo-flavoenzymes (MFEs)
containing two nonidentical [2Fe-2S] clusters and FAD as
additional cofactors [3,4].
Vertebrate xanthine oxidoreductases (XOR) are the products of
single orthologous genes and are the key enzymes in the
catabolism of purines, oxidizing hypoxanthine to xanthine and
xanthine to the terminal catabolite uric acid, with the concomitant
reduction of NAD
+ (XDH) or O2 (XO) [5].
The gene family of vertebrate AOs is much more complex and
the corresponding protein products have been the object of fewer
studies. While the human genome is characterized by a single
functionally active AO gene (AOX1), the complement of
homologous genes in rodents and other mammals is more
complex [4]. Marsupials and rodents contain the highest number
of functionally active AO genes, which generally cluster on the
same chromosomal region at a short distance from one another
[4]. The rodent AO gene cluster consists of the human AOX1
orthologue, and three highly related genes named AO homologue-
1 (AOH1), -2 (AOH2), and -3 (AOH3) [4,6–8]. In other
vertebrates and mammals the number of functionally active loci
varies, as a consequence of gene duplication and suppression
events [4]. The multiple AO isoforms are expressed tissue-
specifically [4,7], and may recognize distinct substrates and carry
out different physiological tasks. The overall level of amino acid
identity between AO and XOR proteins is approximately 50%,
which indicates that the two proteins originated from a common
ancestral precursor [3].
While the biochemical function of XOR is well established, the
biochemical and physiological functions of AO are still largely
obscure [4]. Monogenic deficits of mammalian AO isoforms have
not been reported to date. In humans, AOX1 and XOR do not
seem to play a vital role, as genetic deficiencies in the Moco
sulfurase (MCSF) gene, causing a defect of both enzymes, are
associated with mild symptoms such as the formation of kidney
stones [9,10]. AOs in general are characterized by a broad
substrate specificity and play an important role in the metabolism
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toxicological role, detoxifying xenobiotics of wide structural
diversity. The enzymes oxidize aromatic aza-heterocycles con-
taining a –CH=N2 chemical function (e.g. phtalazine and
purines), aromatic or non-aromatic charged aza-heterocycles with
a –CH=N
+= moiety (e.g. N
1-methylnicotinamide and N-
methylphthalazinium) or aldehydes, such as benzaldehyde, retinal
and vanillin [3]. AO and XOR share some common substrates
and the relative selectivity of the two types of enzymes has been
systematically reviewed [11]. AO may have a role in the
degradation of vitamins like nicotinamide and pyridoxal or in
the oxidation of all-trans retinaldehyde to all-trans retinoic acid, the
active metabolite of vitamin A [3]. Upon oxidation of aldehyde
substrates, AO produces significant amounts of highly toxic
reactive oxygen species, O2
.2 and hydrogen peroxide [12,13].
The reaction mechanism of substrate oxidation of MFEs has
been only described in detail for Rhodobacter capsulatus XDH [14], a
bacterial XDH sharing high similarities to eukaryotic XOR both
at the structural level and on the basis of amino acid sequence
identity [15,16]. In the oxidized enzyme, the metal is in the
Mo(VI) oxidation state, bearing an oxo (=O), an hydroxo (-OH)
and an equatorial sulfido (=S) ligand. Site-directed mutagenesis
showed that GluB730 is a fundamental residue for the catalytic
reaction by abstracting a proton from the Mo-OH group, which
then nucleophilically attacks the substrate carbon atom to be
hydroxylated [14]. Two other conserved residues at the active site
of XORs, GluB232 and ArgB310, are involved in substrate binding
and transition state stabilization [14,17]. In mouse AOX1
(mAOX1), the glutamate acting as an active site base is also
highly conserved (E1265), however, the glutamate involved in
substrate binding is exchanged by a valine (V806), and the
arginine involved in transition state stabilization is exchanged to a
methionine (M884) [3].
To study the importance of these amino acids in substrate
specificity for AOX1, we established a system for heterologous
expression of mAOX1 in E. coli. To ensure a high level of
incorporation of the sulfido ligand at the Moco site, mouse MCSF
(mMCSF) was cloned and coexpressed in this system. The
recombinant enzyme was characterized by spectroscopic methods
and steady state kinetics. Using site-directed mutagenesis, we
exchanged the amino acids present at the active site of mAOX1 by
the ones found in XOR. For comparison reasons, we introduced
the reverse amino acid exchanges to the active site of R. capsulatus
XDH. We determined the kinetic parameters of wild-type and
mutant mAOX1 using different aldehyde and purine substrates,
gaining insights into the molecular determinants guiding substrate
specificity in XOR and AOX1.
Results
Heterologous Expression, Purification and
Characterization of mAOX1
Several heterologous expression systems for mammalian AOs
have been described. However a main drawback of all these
systems is the low catalytic acivity of the purified enzymes due to a
low Moco content [18–20]. To overcome this problem, we
designed an expression system that allowed the simultaneous
expression of mAOX1 and mMCSF in the E. coli TP1000 strain,
and ensured a higher level of sulfurated Moco insertion into the
enzyme [21].
Recombinant mAOX1 was purified from a 12-liter E. coli
culture using sequential Ni-NTA chromatography, size exclusion
chromatography and benzamidine sepharose affinity chromatog-
raphy. The purification protocol used for mAOX1 is summarized
in Table 1. The overall purification from the soluble fraction was
more than 23-fold with a yield of 0.17%, and the final specific
activity with benzalyldehyde of the purified protein was 2.3 U/
mg. This compares well to the activity reported for mAOX1
purified from mouse liver [7]. We demonstrated that the low
increase in specific activity after Ni-NTA is due to the intrinsic
aldehyde oxidizing activity of E. coli enzymes of the xanthine
oxidase family present in the crude extract (data not shown). Size
exclusion chromatography of the purified protein resulted in a
single peak with an approximate molecular mass of 300 kDa,
showing that the protein existed as a homodimer in solution (data
not shown). SDS polyacrylamide gels performed under reducing
conditions demonstrated the presence of one major band with a
size of 150 kDa after purification (Fig. 1). In these experimental
conditions three additional bands with sizes of 120 kDa, 80 kDa,
and 50 kDa were also observed (Fig. 1). Electrospray mass
spectrometry analysis of the respective gel slices revealed that
these bands were degradation products of mAOX1 (data not
shown). These bands were also observed in AO purified from
other sources, e.g. in AO purified from rat liver [12]. As observed
in our data, AO purified from rat liver displayed several bands of
sizes of 150, 130, 80, and 45 kDa on SDS- polyacrylamide gels,
but not after native-PAGE [12]. Thus we conclude, that the
degradaion products occur due the reductive conditions during the
SDS-PAGE.
The visible absorption spectrum (Fig. 2) of recombinant
mAOX1 is similar to those of mAOH1 purified from mouse liver
and shows the presence of FeS and FAD as prosthetic groups [8].
The iron content was measured by ICP-OES and showed a
saturation of 90% (Table 2). Since the ratio of 450:550 in the UV-
Vis spectrum was shown to be 3, this implicates that the protein is
fully saturated with FAD [1]. The Moco content of mAOX1 was
quantified after its conversion to Form A and related to the
molybdenum content of the protein (Table 2), revealing that no
demolybdo-mAOX1 was present in the purified fractions. To
determine the content of the terminal sulfur ligand required for
mAOX1 activity, the cyanolysable sulfur was quantified and in
addition, absorption spectra of oxidized mAOX1 and benzalde-
hyde reduced enzyme were recorded under anaerobic conditions
(data not shown). From the reduction spectra the amount of active
mAOX1 was calculated to be 20%. While purified mAOX1 was
70% saturated with Moco (Table 2), the purified enzyme was only
20% saturated with the sulfido ligand required for enzyme activity.
Table 1. Purification of recombinant mAOX1 after expression
in E. coli TP1000 cells.
Step Volume Protein
a Total
b
Benzaldehyde oxidizing
activity
S.A.
c Yield P.F.
ml mg units units/mg % -fold
Cytosol 150 1611 135 0.1 100 1
Ni-NTA 14 6.6 0.76 0.12 0.57 1.2
Superose 12 15 0.84 0.35 0.43 0.27 4.2
BAS 20 0.1 0.23 2.3 0.17 23
aTotal protein was quantified with the Bradford assay.
bThe activity was measured by monitoring the decrease in absorption at
600 nm in the presence of 500 mM benzaldehyde and 100 mM DCPIP.
cSpecific enzyme activity (units/mg) is defined as the oxidation of 1 mM
benzaldehyde per min and mg of enzyme under the assay conditions.
doi:10.1371/journal.pone.0005348.t001
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Fig. 3 shows the EPR spectra of the FeS clusters of dithionite-
reduced mAOX1 wild-type (trace a), together with the corre-
sponding simulations (traces b–e). The spectra show signals from
the reduced FAD cofactor to the flavin semiquinone and from
some remaining Mo(V). Most prominent are however the
characteristic EPR signals assigned to the two iron sulphur centers
FeSI and FeSII, which are similar for all members of the xanthine
oxidase family that have been described to date [1,22]. FeSI has
EPR properties showing an almost axial g-tensor, similar to those
of many other [2Fe-2S] proteins, being fully developed at
relatively high temperatures (60 K), while FeSII has unusual
EPR properties for [2Fe-2S] species with a strongly rhombic g-
tensor, showing broad lines and being only observed at much
lower temperatures (20 K). The g-values and linewidths were
evaluated by simulating the superimposed spectra of FeSI, FeSII
and reduced FAD (Fig. 3) using the program EasySpin [23]. The
double-integrated simulated spectra for the single iron-sulfur
clusters display a ratio of 1:1 indicating the presence of both
clusters FeSI and FeSII in the same amount in the protein. The
obtained g-values are given in Table 3. The flavin semiquinone
(FAD) has been simulated by using an isotropic g-value of 2.0 and
a linewidth of 1.9 mT. This linewidth is comparable with that
from other flavins [1,22]. The Moco (MoV) has been neglected in
the simulations.
CD-Spectroscopy
CD-spectra were measured in the visible region in both the
reduced and oxidized forms (Fig. 4). The spectrum of the oxidized
wild-type enzyme exhibited strong negative dichroic bands at
approximately 350–400 nm and 520–580 nm, and intensive
positive bands between 400 and 500 nm (Fig. 4). From the
various maxima and infections, transitions can be identified at 378
(2), 434 (+), 474 (+), and 556 (2) nm. Upon reduction with
dithionite, the spectrum changed markedly with less intense
transitions at 370 (2), 408 (+), and 478 (2) nm. The visible CD-
Figure 1. Purification of mAOX1 after heterologous expression
in E. coli. 12% SDS-PAGE analysis of purification of mAOX1. The
protein was purified after Ni-NTA, Superose 12 and benzamidine
sepharose 6B. Purified mAOX1 displays a molecular mass of 150 kDa on
SDS-PAGE, the three bands with sizes of 120 kDa, 80 kDa, and 50 kDa
correspond to degradation products of mAOX1, as determined by mass
spectrometry.
doi:10.1371/journal.pone.0005348.g001
Figure 2. Characterization of wild-type mAOX1 by UV-VIS
absorption spectroscopy. Spectra of 7 mM of the air-oxidized
mAOX1 in 50 mM Tris, 1 mM EDTA, pH 7.5, under anaerobic conditions.
doi:10.1371/journal.pone.0005348.g002
Table 2. Determination of the Moco and iron content of
mAOX1 and R. capsulatus XDH and variants.
Protein Moco content
a % Fe-content
b %
mAOX1:
WT 70 90
V806E 46 101
M884R 66 97
V806E/M884R 44 108
E1265Q 60 83
Rc XDH:
WT 75 99
E232V 43 95
R310M 63 88
E232V/R310M 49 97
aMoco was quanitfied as described in Materials and Methods. Moco content of
wild-type mAOX1 and R. capsulatus XDH was set to the calculated
molybdenum content determined by ICP-OES, and Moco determined as Form
A in the AOX1 variants was compared to that value.
bIron was determined by ICP-OES as described in Materials and Methods.
doi:10.1371/journal.pone.0005348.t002
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and intensity to those of XOR [24,25], showing that both FeSI
and FeSII are present in the recombinant enzyme.
Steady state kinetics of mAOX1 wild-type and active site
variants E1265Q, V806E, M884R, and V806E/M884R
To determine the role of amino acids Glu1265, Val806, and
Met884 for the oxidation of aldehydes by mAOX1, the variants
E1265Q, V806E, M884R, and the double variant V806E/
M884R were generated and purified. Fig. 5 shows wild-type
mAOX1 with the purified variants on a native polyacrylamide gel,
showing that all proteins had about the same purity.
Since some of the variants were inactive with benzaldehyde, the
Moco content of the variants was determined in comparison to
wild-type mAOX1, and showed the following range of Moco
saturation: E1265Q 60%, V806E 46%, M884R 66%, and
V806E/M884R 44% (Table 2). The lower Moco content of the
purified variants may be due to the modified purification protocol
necessary for the purification of these mAOX1 variants, which did
not bind to the benzamidine sepharose. The iron content of the
variants varied between 83–108%, reflecting that the FeS clusters
were not influenced by the amino acid exchanges at the active site
(Table 2). In addition, the variants showed almost identical CD-
spectra in comparison to wild-type mAOX (data not shown).
With the exception of retinaldehyde, steady state kinetics of wild-
type mAOX1 were performed by varying the concentrations of the
substrates benzaldehyde, phtalazine, acetaldehyde, xanthine and
hypoxanthine, and by using DCPIP as electron acceptor (Experi-
mental procedures). In consideration of the fact that the protein was
only 20% active, the enzyme activities compared well to the values
obtained for native mAOX1 [7]. In particular the kcat values
determined with benzaldehyde were almost superimposable
(Table 4). The kcat values determined for retinaldehyde and
Table 3. EPR linewidths and g-values of FeSI and FeSII from
mAOX1.
Protein Cluster g-values linewidth [mT]
gx gy gz
Rabbit liver AO
a FeSI
a 2.018 1.930 1.918 1.6
FeSII
a 2.106 2.003 1.915 -
mAOX1 FeSI
b 2.019 1.927 1.912 2.6
FeSII
c 2.085 1.971 1.90 4.0
aAOX wild-type from rabbit liver, values from [36].
bg-strain was included in the simulation with 0.01 for gz .
cg-strain was included in the simulation with 0.04 for gx . Estimated error of g-
values: 60.004 for FeSI and 60.008 for FeSII.
doi:10.1371/journal.pone.0005348.t003
Figure 3. EPR spectra of mAOX1 wild-type. Experimental cw-EPR
spectra of dithionite-reduced mAOX1 wild-type samples at pH 7.0
(trace a) together with the corresponding simulation (trace b). For
simulation parameters see Table 3. The flavin semiquinone was
simulated with an isotropic g-value of giso=2.0 and 1.9 mT (trace e).
(MoV) was neglected in all simulations. (a) mAOX1 wild-type; (b)
simulation of complete spectrum; (c) simulation of FeSI; (d) simulation
of FeSII; (e) simulation of FAD. Experimental conditions: T=20 K, 1 mW
microwave power, 1 mT modulation amplitude, 12.5 kHz modulation
frequency.
doi:10.1371/journal.pone.0005348.g003
Figure 4. CD-Spectroscopy of mAOX1 wild-type. Spectra were
recorded in 50 mM Tris, 1 mM EDTA, pH 7.5 at 10uC using a Jasco J-715
CD-spectrometer. Spectra of 2.1 mg/mL of mAOX1 were recorded in
the oxidized state (solid lines) and after reduction with sodium
dithionite (dotted lines).
doi:10.1371/journal.pone.0005348.g004
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but were in the same range. The substrates with the highest catalytic
efficiency were the aromatic aldehydes phtalazine, benzaldehyde
and retinaldehyde. Acetaldehyde showed the lowest catalytic
efficiency. The purine substrates xanthine and hypoxanthine were
not used by the recombinant mAOX1 under our assay conditions.
The catalytic parameters for the mAOX1 variants E1265Q,
V806E, M884R, and V806E/M884R were also determined. As
shown in Table 4, variants E1265Q and V806E/M884R were
unable to metabolize any of the aldehyde and purine substrates
tested. While the corresponding kcat valueswere generallydecreased,
the Km value for benzaldehyde, phtalazine and acetaldehyde were
drasticallyincreased byintroducingtheV806Eaminoacid exchange
in mAOX1. For the variant V806E, the catalytic efficiency
decreased by a factor of 10 for benzaldehyde, retinaldehyde and
acetaldehyde,while thevalue wasonly decreased 3-foldfor phtalzine
as substrate. Thus, the affinity for small and symmetric aromatic
aldehydes are affected by this mutation, while the affinity for more
hydrophobic aldehydes like retinaldehyde was increased, albeit with
a concomitant decrease in kcat. In contrast, the M884R variant was
inactive with phtalazine and acetaldehyde as substrates, and for both
benzaldehyde and retinaldehyde kcat and Km were decreased.
Comparison of steady state parameters of the reverse
amino acid exchanges (EB232V, RB310M, and EB232V/
RB310M) introduced into R. capsulatus XDH
The catalytic mechanism of R. capsulatus XDH was proposed to
involve three amino acids at the active site: GluB730 is thought to
act as an active site base in the initial step of the reaction, while
GluB232 is involved in substrate binding and transition state
stabilization and RB310 is involved in transition state stabilization
and orientation of the substrate at the active site. Since the
catalytic mechanism of R. capsulatus XDH is well characterized, we
compared the steady state kinetic data derived for wild-type
mAOX1 and active-site variants with amino acid exchanges
introduced into the active site of R. capsulatus XDH to reverse the
amino acids found at the active site of XDH to the ones conserved
in mAOX1. Thus, the XDH variants EB232V, RB310M, and the
double variant EB232V/RB310M were generated.
Table 4. Steady-state kinetic parameters of recombinant mAOX1 and variants with different aldehyde and purine substrates.
substrate Kinetic parameters
a mAOX1-WT V806E M884R V806E/M884R E1265Q
benzaldehyde Km[mM] 97.7621.5 634.5676.4 713062580 n.d. n.d.
kcat[min
21] 317.6628.5 151.0620.8 76.4617.8 n.d. n.d.
kcat/Km[mM
1 min
21] 3.3460.56 0.2460.02 0.01160.002 - -
phthalazine Km[mM] 11.464.0 28.5560.35 n.d. n.d. n.d.
kcat[min
21] 128.1613.0 103.061.0 n.d. n.d. n.d.
kcat/Km[mM
1 min
21] 12.264.0 3.660.1 - - -
retinaldehyde Km[mM] 55.868.8 22.262.8 7.562.0 n.d. n.d.
kcat[min
21] 49.568.7 13.962.4 1.360.4 n.d. n.d.
kcat/Km[mM
1 min
21] 0.8960.02 0.6360.04 0.1760.02 - -
acetaldehyde Km[mM] 1750064900 52900617800 n.d. n.d. n.d.
kcat[min
21] 519.96112.3 160.6638.1 n.d. n.d. n.d.
kcat/Km[mM
1 min
21] 0.03060.002 0.003160.0003 - - -
xanthine Km[mM] n.d. n.d. n.d. n.d. n.d.
kcat[min
21] n.d. n.d. n.d. n.d. n.d.
kcat/Km[mM
1 min
21] -- - - -
hypoxanthine Km[mM] n.d. n.d. n.d. n.d. n.d.
kcat[min
21] n.d. n.d. n.d. n.d. n.d.
kcat/Km[mM
1 min
21] -- - - -
aApparent kinetic parameters were recorded in 50 mM Tris, 1 mM EDTA, pH 7.5 by varying the concentration of substrate in the presence of 100 mM DCPIP as electron
acceptor.
n.d., none was detectable.
-, not determined.
doi:10.1371/journal.pone.0005348.t004
Figure 5. Native PAGE of mAOX1 wild-type and variants after
purification. Purified enzymes were analyzed by 7% native PAGE. Each
lane contained 6 mg of purified enzyme: lane 1, mAOX1 wild-type; lane
2, mAOX1-V806E; lane 3, mAOX1-M884R; lane 4, mAOX1-V806E/M884R;
lane 5, mAOX1-E1265Q.
doi:10.1371/journal.pone.0005348.g005
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proteins was reduced and varied from 43%–63%, depending on
the introduced amino acid exchange. Steady state kinetics of XDH
were performed by varying the concentrations of the substrates
benzaldehyde, phtalazine, retinaldehyde, acetaldehyde, xanthine
and hypoxanthine, by using DCPIP as electron acceptor.
Compared to wild-type XDH, the activity of the variants with
purine substrates was drastically decreased, while oxidation of
aldehydes as substrate was increased (Table 5). We were able to
sucessfully purify the XDH-EB232V/RB310M double variant.
This variant was devoid of purine oxidizing activity (Table 5),
however, in contrast, aldehydes were oxidized with a higher
turnover number in comparison to wild-type XDH. In general, the
kcat values of the three XDH variants for all aldehyde substrates
tested was increased, while the Km was decreased for benzadehyde
and phtalazine and increased for retinaldehyde and acetaldehyde.
Overall, the results obtained for R. capsulatus XDH show that the
two amino acids at the active site switch the substrate specificity
from purines to aldehydes. However, the reverse was not true for
amino acids exchanges in the active site of mAOX1, showing that
the oxidation of aldehydes is more complex.
Discussion
Here, we report a system for the heterologous expression of
mAOX1 in E. coli. Our system tried to overcome one of the main
problems associated with the expression of recombinant mamma-
lian MFEs in bacteria, i.e. the production of large proportions of
inactive demolybdo and desulfo enzymes, as observed in the case
of human XOR [20]. To ensure a higher sulfuration level of
AOX1, we engineered E. coli for the simultaneous synthesis of the
mMCSF and mAOX1 proteins. After coexpression with mMCSF,
mAOX1 contained a 50% higher level of the terminal sulfido
ligand of Moco (data not shown), although only 20% of the
purified enzyme existed in the catalytically active form. This
suggested two possibilities: either the conditions for the expression
of both proteins have to be further optimized, or the sulfuration of
Moco in bacteria and eukaryotes is different. Thus in prokaryotes,
sulfuration of Moco precedes insertion into MFEs [26]. In
eukaryotes, like Arabidopsis thaliana it was speculated that Moco
sulfurase sulfurates Moco already bound to MFEs [27]. Thus it
remains possible that due to this difference, heterologous
expression of mammalian MFE’s in E. coli will not give rise to a
complete sulfurated enzyme. However, we also tried expression of
AOX1 in Pichia pastoris, and this expression system also did not
give rise to a higher sulfuration level of AOX1. Thus, it also
remains possible, that part of the sulfido ligand of mAOX1 is
exchanged to an oxo-ligand during purification of the enzyme.
The recombinant mAOX1 displayed similar catalytic properties
in comparison to the enzyme purified from mouse liver [7]. This
demonstrates that the protein was correctly folded in mMCSF
engineered E. coli cells and could be used for more detailed
analyses. The EPR spectra of mAOX1 were found to be very
similar to those from the bacterial XDH characterized from R.
capsulatus, showing a rather axial signal for FeSI [28]. There are
only subtle differences in the g-values and linewidths, in particular
for the FeSII center, that may be the consequence of small changes
in bond distances and angles of the ligands of the respective FeS
centers [28]. Nevertheless, the overall close similarity of the EPR
parameters indicated the presence of the same ligands and similar
geometries of the two redox centers in mAOX1 and R. capsulatus
XDH. The spectroscopic charactaristics of mAOX1 and rabbit
Table 5. Steady-state kinetic parameters of recombinant R. capsulatus XDH and variants with different aldehyde and purine
substrates.
substrate Kinetic parameters
a XDH-WT E232V R310M E232V/R310M
benzaldehyde Km[mM] 5406146 39.967.0 5526188 25.9615.5
kcat[min
21] 3362 93.5613.6 211653 94.268.4
kcat/Km[mM
1 min
21] 0.06360.013 2.460.1 0.3660.08 4.161.3
phthalazine Km[mM] 12406210 310680 n.d. 420673
kcat[min
21] 2.6260.06 142.0627.4 n.d. 81.0610.5
kcat/Km[mM
1 min
21] 0.002260.0004 0.4760.04 - 0.2060.02
retinaldehyde Km[mM] 6.361.3 38.2610.5 154.867.1 36.661.1
kcat[min
21] 0.3960.06 3.360.9 10.960.2 3.060.2
kcat/Km[mM
1 min
21] 0.06360.005 0.08760.003 0.07160.003 0.08260.005
acetaldehyde Km[mM] n.d. 9136460 620061880 21706450
kcat[min
21] n.d. 88.5620.1 110.6610.9 56.867.6
kcat/Km[mM
1 min
21] - 0.1160.03 0.01960.004 0.02760.005
xanthine Km[mM] 59610 17567 n.d. n.d.
kcat[min
21] 33006460 85.6615.3 n.d. n.d.
kcat/Km[mM
1 min
21] 56.466.6 0.4960.07 - -
hypoxanthine Km[mM] 31.461.4 n.d. 63.7610.1 n.d.
kcat[min
21] 26666186 n.d. 9.060.3 n.d.
kcat/Km[mM
1 min
21] 84.863.4 - 0.1460.03 -
aApparent kinetic parameters were recorded in 50 mM Tris, 1 mM EDTA, pH 7.5 by varying the concentration of substrate in the presence of 100 mM DCPIP as electron
acceptor.
n.d., none was detectable.
-, not determined.
doi:10.1371/journal.pone.0005348.t005
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signal for FeSI.
Eukaryotic XOR and AO are similar in protein structure and
prosthetic group composition, but have different characteristics of
substrate specificity both at the molybdenum center and at the
FAD center [3,11]. While mAOX1 is a true oxidase using
molecular oxygen as electron acceptor at the FAD site, XOR
exists in two interconvertible forms: NAD
+ is the substrate for the
XDH form of XOR, while after proteolytic cleavage or
intramolecular disulfide formation, the XO form is generated,
which uses O2 instead of NAD
+. The hydroxylation of aldehyde
and purine substrates is catalyzed at the molybdenum center in
both AO and XOR. However, the former catalyzes the
hydroxylation of aldehydes more efficiently than the latter [11].
On the other hand, purines such as hypoxanthine and xanthine
are good substrates of XOR, but poor substrates of AO. The
crystal structure of R. capsulatus XDH with alloxanthine bound to
the active site [15], in addtion to site directed mutagenesis studies
[14], proposed that the purine substrates are bound and oxidized
as follows: Catalysis is initiated by abstraction of a proton from the
Mo-OH group by the conserved active site GluB730, followed by
the nucleophilic attack on the carbon of the substrate and the
concomitant hydride transfer to the Mo=S of the molybdenum
center [14]. This reaction yields an intermediate with the
hydroxylated product coordinated to the molybdenum via the
newly introduced hydroxyl group. The catalytic sequence is
completed by displacement of the bound product from the
molybdenum coordination sphere by hydroxide from solvent. This
is followed by intramolecular electron transfer to the FeS and FAD
cofactors, as well as deprotonation of the Mo-SH to give the
oxidized form of the molybdenum center. In addition, GluB232
and ArgB310 of R. capsulatus XDH were shown to be involved in
the binding, orientation and transition state stabilization of the
substrate [14,17].
A similar reaction mechanism as the one described for XOR
have been proposed for AOs [4], although, this proposal has never
been supported by experimental data based on site-directed
mutagenesis. Heterologous expression of mAOX1 in E. coli
enabled us to study the involvement of specific residues at the
active site in more detail for the first time. We exchanged residues
Glu1265, Val806, and Met884 to the ones identified in the active
site of XORs. For direct comparison reasons, the reverse amino
acid exchanges were introduced to the active site of R. capsulatus
XDH. Our results showed that the amino acid exchanges in XDH
resulted in the complete loss of activity towards purine substrates
for the EB232V/RB310M double variant, and a higher activity
with aldehyde substrates. In contrast to Yamaguchi et al. [20], we
were able to purify the EB232V/RB310M double XDH variant.
However, the reverse was not the case for amino acid exchanges in
mAOX1. The amino acid exchanges V806E/M884R in mAOX1
resulted in a complete loss of enzyme activity with both purine and
aldehyde substrates. Both residues at the active site of mAOX1
seem to be important for the binding of substrates, since the
M884R variant either completely lost the activity with phtalazine
or acetaldehyde as substrates, or the activity with retinaldehyde
and benzaldehyde was drastically reduced, with a concomitant
increase of Km for benzaldehyde. In general, the V806E exchange
resulted in an increase in Km for most substrates (except
retinaldehyde) and in a decrease in kcat. Thus, while the ability
to bind and utilize aldehyde substrates was decreased by
converting the two residues to the ones found in XDH, purines
were still not converted by the mAOX1 variants. While in XDH
the two residues seem to determine which substrates are efficiently
bound at the active site, in mAOX1 more factors determine the
binding and conversion of substrates. mAOX1 seems to be more
adapted to aldehyde substrates and the substrate specificity can not
be converted back to purine substrates by two amino acid
exchanges at the active site. The active site of XDH is deeply
buried in the enzyme, but reachable through a funnel-shaped
cavity that is wider on the surface. Hydrophobic residues, able to
accommodate the ring structures of the aromatic substrates
dominate the channel in XOR (e.g. LeuB303, ProB306, PheB344,
PheB459 in R. capsulatus XDH) [15]. These residues are exchanged
to more bulky, charged or hydrophobic amino acids in mAOX1:
Glu877, Trp880, Phe918, and Ile1013 [3]. It is possible that the
aromatic purine residues analyzed in this study, are unable to
enter the active site of mAOX1.
Finally, the mAOX1-E1265Q variant was catalytically inactive.
This result is consistent with an essential catalytic role for this
residue [4]. Like in XOR, Glu1265 of mAOX1 may function as
an active-site base to abstract a proton from the Mo-OH leading
to the nucleophilic attack on the aldehyde substrate molecule,
which is followed by a hydride transfer to give the transition state
intermediate (Fig. 6). The roles of residues Met884 and Val806 are
proposed to be the stabilization of substate binding. Since the
aromatic aldehydes tested in this study are symmetric, the
orientation of the substrate at the active site is not as important
as in XOR [17].
In total, the established expression system of mAOX1 in E. coli
can further be used for detailed site-directed mutagenesis and
structure-function studies of mammalian MFEs. In future studies it
is planned to characterize the homologues of mAOX1 in rodents
in more detail. Analysis of substrate specificities will give insights
into the potential physiological roles of these enzymes.
Materials and Methods
Bacterial Strains, Plasmids, Media and Growth Conditions
E.coli TP1000 (DmobAB) cells [30] were used for the coexpres-
sion of mAOX1 wild-type and variants with mMCSF. E. coli
expression cultures were grown in LB medium under aerobic
conditions at 30uC for 24 h. Ampicillin (50 mg/ml) chloramphen-
icol (150 mg/ml), sodium molybdate (1 mM) and isopropyl-ß-D-
thiogalactoside (IPTG) (20 mM) were used when required.
Cloning Expression and Purification of mouse AOX1 and
variants
The cDNA of mAOX1 was cloned from mouse CD1 liver [31],
using primers designed to allow cloning into the NdeI-SalI sites of
the expression vector pTrcHis [32]. The resulting plasmid was
designated pSL205, and expresses mAOX1 as a N-terminal fusion
protein with a His6-tag. By using PCR mutagenesis the amino acid
exchanges V806E, M884R, V806E/M884R and E1265Q were
introduced into mAOX1. The mMCSF cDNA fragment was
cloned from mouse liver using primers for the cloning into the
NdeI-XhoI sites of the expression vector pACYCDuet-1 (Novagen),
and the resulting plasmid was designated pSS110.
For heterologous expression in E. coli, pSL205 and pSS110 were
transformed into TP1000 cells [30]. To express recombinant
proteins, cells were grown at 30uC in LB medium supplemented
with 150 mg/mL ampicillin, 50 mg/ml chloramphenicol, 1 mM
molybdate, and 20 mM IPTG. After 24 h, cells were harvested by
centrifugation, resuspended in 50 mM sodium phosphate buffer,
pH 8.0, containing 300 mM NaCl and disrupted by several
passages through a French Press cell. The supernatant was mixed
with 3.5 mL of Ni-nitrilotriacetic (NTA) resin per 12 liters of cell
growth. The slurry was transferred to a column and washed with
10 column volumes of 50 mM sodium phosphate, 300 mM NaCl,
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column volumes of the same buffer containing 20 mM imidazole.
His6-tagged mAOX1 was eluted with 50 mM sodium phosphate,
300 mM NaCl, pH 8.0 containing 250 mM imidazole. This
fraction was dialyzed over night in 50 mM Tris-HCl, 200 mM
NaCl, pH 7.5, containing 1 mM EDTA. The mAOX1 protein
was further applied to a Superose 12 gel filtration column (GE
Healthcare). The eluted fractions were analyzed by SDS-PAGE
and the ones containing mAOX1 were combined and dialyzed
against 100 mM Glycin, 200 mM NaCl, pH 9.0. The mAOX1
protein was mixed with 2 ml of benzamidine sepharose (GE
Healthcare), pre-equilibrated in the same buffer. Following 4 h of
incubation, the resin was washed 3 times with 10 ml of the
equilibration buffer to remove unbound proteins. Absorbed
proteins were eluted with 20 ml of equilibration buffer containing
30 mM benzamidine. Subsequently, the eluted protein was
dialyzed into 50 mM Tris-HCl, pH 7.5 containing 1 mM EDTA.
The protein solution was then concentrated by ultrafiltration.
Absorbance spectra were recorded with a Shimadzu UV-2401
dual-wavelength double-beam spectrophotometer. Purified pro-
teins were stored at 270uC until use. The mAOX1 variants were
expressed under the same conditions as the mAOX1 wild-type and
purified by Ni-NTA and Superose 12 chromatography.
Site-directed mutagenesis and purification of R.
capsulatus XDH and variants
R. capsulatus wild-type XDH was purified as described previously
[14]. Using PCR mutagenesis amino acid exchanges EB232V,
RB310M, and the double variant EB232V/RB310M were
introduced into R. capsulatus XDH. The generated XDH variants
were purified by Ni-NTA, Q-Sepharose, and Superose 12
chromatography as described previously for other XDH variants
[14]. The purified enzymes were concentrated by ultrafiltration,
gel filtered using a PD-10 gel filtration column (GE Healthcare)
equilibrated with 50 mM Tris, 1 mM EDTA, 2.5 mM DTT,
pH 7.5 and stored at 270uC until used.
SDS-polyacrylamide Gel Electrophoresis (PAGE)
SDS-PAGE was performed as described by Laemmli [33] using
12% polyacrylamide gels. The gels were stained with Coomassie
Brilliant Blue R.
Enzyme assays
Enzyme assays were carried out at 30uC in Tris buffer (50 mM,
1 mM EDTA, pH 7.5) in a final volume of 500 mL. Total enzyme
concentration was 30 nM for wild-type mAOX1 and 30–200 nM
for the variants. Enzyme activity was monitored spectrophoto-
metrically at 600 nm with 100 mM 2,6-dichlorphenolindophenol
(DCPIP) as electron acceptor and calculated using the extinction
coefficient of 16.1 mM
21 cm
21 for DCPIP [34].
To determine retinaldehyde oxidase activity, the assay described
by Vila et al. [7] was used with some modifications. Purified
mAOX1 (2 mg) was incubated in the dark for 10 min at 30uCi n
100 mL of 10 mM potassium phosphate buffer, pH 7.4 and the
reaction was started by the addition of 0.01–10 mM all-trans-
retinaldehyde. The reaction was stopped with 100 mL of butanol/
methanol (95:5 v/v) containing 0.005% w/v of butylated
hydroxytoluene (0.005% w/v) (Sigma-Aldrich). The organic phase
was separated and 20 mL were subjected to high performance
liquid chromatography on a C18 reverse phase column (4.66250-
mm ODS Hypersil, 5 mm). The production of the oxidation
product all-trans-retinoic acid was determined at 340 nm and
quantified by using a calibration curves.
Absorption Spectra during Anaerobic Reduction
Purified mAOX1 in 150 mLo f5 0 m MT r i s ,1m ME D T A ,
pH 7.5, was incubated in an anaerobic chamber (Coy Lab Systems)
for2 hat4uCbeforebenzaldehydewasaddedtoafinalconcentration
of 300 mM. Complete reduction was achieved by the addition of
20 mM sodium dithionite. Spectra were recorded in 0.15 mL
cuvettes using a Shimadzu UV-2401 PC spectrophotometer.
Metal and Moco/MPT analysis
The molybdenum and iron contents of the purified proteins
were quantified by ICP-OES analysis with a Perkin-Elmer Optima
2100 DV. The samples were wet-ashed at a concentration of
4 mM in a volume of 500 mL by the addition of 500 mM 65%
nitric acid and incubated over night at 100uC. The samples were
further diluted by the addition of 4 mL of water. As reference, the
multi-element standard solution XVI (Merck) was used. The
complete Moco content of mAOX1 in comparison to the variants
was quantified after conversion to its fluorescent degradation
product Form A as described earlier [35].
CD-spectroscopy
UV/visible CD spectra of 2.1 mg/mL enzyme samples were
recorded in 50 mM Tris, 1 mM EDTA, pH 7.5 using a Jasco J-
715 CD-spectrophotometer. The scanning mode was set step-wise,
each nm a data pitch was recorded, the response time was
2 seconds and each measurement was repeated 4 times.
Figure 6. Proposed base catalyzed mechanism for mAOX1. E1265 acts as an active site base that abstracts a proton from the Mo-OH group,
which in turn undertakes a nucleophilic attack on the substrate benzaldehyde. After hydride transfer to the Mo=S group, the initial intermediate
breaks down, with the transient formation of a paramagnetic Mo
V species, followed by displacement of product by a water molecule to return to the
starting LMo
VIOS(OH) state. The roles of residues Met884 and Val806 are stabilization of substrate binding.
doi:10.1371/journal.pone.0005348.g006
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9.5 GHz X-band EPR spectra were recorded on a Bruker
ESP300E spectrometer equipped with a TE102 microwave cavity.
For temperature control between 5 K und 300 K an Oxford ESR
900 helium flow cryostat with an Oxford ITC4 temperature
controller was used. The microwave frequency was detected with
an EIP frequency counter (Microwave Inc.). Magnetic field was
calibrated using a LiLiF standard with a known g-value of
2.00229360.000002 [36]. Samples (typically 0.1 mM enzyme)
were prepared in quartz tubes with 4 mm outer diameter.
Chemical reduction, in order to generate the reduced Fe(II)/
Fe(III) in the FeS clusters, was performed by adding a small
volume of anaerobic sodium dithionite solution to the protein
solution under a weak stream of argon gas (20-fold excess
dithionite with respect to the protein). The sample tubes were
frozen, after a change of colour was observed (typically 30 s
reaction time) in liquid nitrogen. Baseline corrections, when
required, were performed by subtracting a background spectrum,
obtained under the same experimental conditions from a sample
containing only a buffer solution. Simulations of the experimental
EPR spectra, based on a spin Hamilton operator approach, were
performed with the program EasySpin [23]. Second integrals from
the simulated spectra of reduced FeSI and FeSII were used to
estimate the relative amount of both clusters in the respective
samples.
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